Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h

Lignende værker

• Safety, local tolerability and pharmacokinetics of ceftaroline fosamil administered in a reduced infusion volume
  af: Edeki, Timi, et al.
  Udgivet: (2014)
• Comparison of In Vivo and In Vitro Pharmacodynamics of a Humanized Regimen of 600 Milligrams of Ceftaroline Fosamil Every 12 Hours against Staphylococcus aureus at Initial Inocula of 10(6) and 10(8) CFU per Milliliter
  af: So, Wonhee, et al.
  Udgivet: (2014)
• Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy
  af: Casapao, Anthony M., et al.
  Udgivet: (2014)
• Single- and Multiple-Dose Study To Determine the Safety, Tolerability, and Pharmacokinetics of Ceftaroline Fosamil in Combination with Avibactam in Healthy Subjects
  af: Riccobene, Todd A., et al.
  Udgivet: (2013)
• A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
  af: Dryden, Matthew, et al.
  Udgivet: (2016)